Found: 5
Select item for more details and to access through your institution.
Impact of tafamidis on myocardial strain in transthyretin amyloid cardiomyopathy.
- Published in:
- Amyloid, 2023, v. 30, n. 1, p. 127, doi. 10.1080/13506129.2022.2131385
- By:
- Publication type:
- Article
Myocardial structural and functional changes in cardiac amyloidosis: insights from a prospective observational patient registry.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2024, v. 25, n. 1, p. 95, doi. 10.1093/ehjci/jead188
- By:
- Publication type:
- Article
Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2023, v. 24, n. 8, p. 1019, doi. 10.1093/ehjci/jead030
- By:
- Publication type:
- Article
Health-related quality of life is an independent predictor of mortality and hospitalisations in transthyretin amyloid cardiomyopathy: a prospective cohort study.
- Published in:
- Quality of Life Research, 2024, v. 33, n. 10, p. 2743, doi. 10.1007/s11136-024-03723-y
- By:
- Publication type:
- Article
Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis—A Retrospective Austrian Multicenter Study.
- Published in:
- Biomedicines, 2022, v. 10, n. 12, p. 3052, doi. 10.3390/biomedicines10123052
- By:
- Publication type:
- Article